UNLIMITED FREE
ACCESS
TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

ASTM International - ASTM E3483-25

Standard Test Method for Evaluating the Impact of Nanomaterials on Phagocytic Function in Vitro

active
Buy Now
Organization: ASTM International
Publication Date: 15 April 2025
Status: active
Page Count: 8
ICS Code (Nanotechnologies): 07.120
ICS Code (Medical science): 11.020.20
significance And Use:

5.1 This test method evaluates the effects of nanomaterials on the phagocytic function of phagocytic cells.

5.2 This luminol chemiluminescence-based assay is a measure of "phagocytic... View More

scope:

1.1 This test method covers a procedure for evaluating the effect of a nanomaterial on phagocytic cellular function.

1.2 Phagocytes play an important role in both innate and adaptive immunity.

1.3 Testing the effect of nanomaterials on phagocytic function using phagocytic cells in vitro helps to predict the biocompatibility of drug formulations and medical devices that contain nanomaterials.

1.4 This procedure can be used to test the effect of other materials, including excipients and ions generated from the nanomaterial, on phagocytic cellular function.

1.5 This test method is intended to strengthen understanding of the potential for adverse health effects of nanomaterials on cellular phagocytic function and subsequent risk of compromising protective innate immunity on systemic administration of nanomaterials.

1.6 This test method uses an in vitro model with peripheral blood-derived human acute promyelocytic leukemia (HL-60) cells to measure zymosan A uptake via luminol chemiluminescence. HL-60 is an immortalized cell line capable of phagocytosis derived from a single donor.

1.7 This test method does not apply to nanomaterials that interfere with luminol chemiluminescence.

1.8 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.9 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

Document History

ASTM E3483-25
April 15, 2025
Standard Test Method for Evaluating the Impact of Nanomaterials on Phagocytic Function in Vitro
1.1 This test method covers a procedure for evaluating the effect of a nanomaterial on phagocytic cellular function. 1.2 Phagocytes play an important role in both innate and adaptive immunity. 1.3...
Advertisement